Trademarkia Logo

Canada

C$
Trademark Search in Canada
MTAMRIO

View On IC.GC.CA

MTAMRIO
ABANDONED SECTION 36

on 17 Feb 2025

Last Applicant/ Owned by

Mirati Therapeutics, Inc.

Suite 2009393 Towne Centre DriveSan Diego, CA 92121

US

Serial Number

1992638 filed on 28th Oct 2019

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

MTAMRIO

Trademark usage description

pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical prepara Read More

Classification Information

Class [005]
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors

Classification kind code

11

Class [042]
Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Classification kind code

11

Mark Details

Serial Number

1992638

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 6
on 17th Feb 2025		Abandoned - Section 36
Submitted for opposition 14
on 28th Nov 2024		Default Notice Sent
Submitted for opposition 22
on 10th May 2024		Search Recorded
Submitted for opposition 20
on 10th May 2024		Examiner's First Report
Submitted for opposition 67
on 7th Oct 2022		Agent Name Changed
Submitted for opposition 287
on 13th Apr 2022		Pre-Assessment Letter Sent
Submitted for opposition 135
on 30th Jan 2020		Amendment to Application
Submitted for opposition 31
on 14th Nov 2019		Formalized
Submitted for opposition 30
on 28th Oct 2019		Filed
Submitted for opposition 1
on 28th Oct 2019		Created